• Менеджмент болевого синдрома после родов Мнение комитета экспертов Американского колледжа акушеров и гинекологов Номер 742 • Июль 2018 г.
К содержанию

Менеджмент болевого синдрома после родов Мнение комитета экспертов Американского колледжа акушеров и гинекологов Номер 742 • Июль 2018 г.

HEALTH OF WOMAN. 2018.6(132):134–139

Сокращенный вариант. Адаптировано – С.А. Шурпяк

СПИСОК ЛИТЕРАТУРЫ

1. Eisenach JC, Pan PH, Smiley R, Lavand’homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain 2008;140:87–94. 
2. Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol 2016;215:353.e1–18. 


3. Centers for Disease Control and Prevention. Breastfeeding report card progressing toward national breastfeeding goals. United States, 2016. Atlanta (GA): CDC; 2016. Avail– able at: https://www.cdc.gov/breastfeeding/pdf/2016breast feedingreportcard.pdf. Retrieved March 9, 2018. 


4. World Health Organization. Cancer pain relief. Geneva: WHO; 1986. Available at: http://apps.who.int/iris/bitstream/ handle/10665/43944/9241561009_eng.pdf. Retrieved March 26, 2018. 


5. Leung L. From ladder to platform: a new concept for pain management. J Prim Health Care 2012;4:254–8. 


6. Carvalho B, Butwick AJ. Postcesarean delivery analgesia. Best Pract Res Clin Anaesthesiol 2017;31:69–79. 
7. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain man– agement in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012;116:248–73. 


8. Corso E, Hind D, Beever D, Fuller G, Wilson MJ, Wrench IJ, et al. Enhanced recovery after elective caesarean: a rapid review of clinical protocols, and an umbrella review of systematic reviews. BMC Pregnancy Childbirth 2017;17:91. 


9. Dennis CL, Jackson K, Watson J. Interventions for treating painful nipples among breastfeeding women. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No.: CD007366. 


10. Vieira F, Mota DD, Castral TC, Guimaraes JV, Salge AK, Bachion MM. Effects of anhydrous lanolin versus breast milk combined with a breast shell for the treatment of nipple trauma and pain during breastfeeding: a randomized clinical trial. J Midwifery Womens Health 2017;62:572–9. 


11. Berens P, Eglash A, Malloy M, Steube AM. ABM clinical protocol #26: persistent pain with breastfeeding. Academy of Breastfeeding Medicine. Breastfeed Med 2016;11:46–53. 


12. Fahey JO. Best practices in management of postpartum pain. J Perinat Neonatal Nurs 2017;31:126–36. 


13. Deussen AR, Ashwood P, Martis R. Analgesia for relief of pain due to uterine cramping/involution after birth. 
Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD004908.

14. Hedayati H, Parsons J, Crowther CA. Topically applied anaesthetics for treating perineal pain after childbirth. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004223.

15. East CE, Begg L, Henshall NE, Marchant PR, Wallace K. Local cooling for relieving pain from perineal trauma sus– tained during childbirth. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD006304.

16. Mounsey AL, Halladay J, Sadiq TS. Hemorrhoids. Am Fam Physician 2011;84:204–10.

17. Chou D, Abalos E, Gyte GM, Gülmezoglu AM. Paraceta– mol/acetaminophen (single administration) for perineal pain in the early postpartum period. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD008407.

18. Wuytack F, Smith V, Cleary BJ. Oral non-steroidal anti– inflammatory drugs (single dose) for perineal pain in the early postpartum period. Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD011352.

19. Khan MI, Walsh D, Brito-Dellan N. Opioid and adjuvant analgesics: compared and contrasted. Am J Hosp Palliat Care 2011;28:378–83.

20. Laska EM, Sunshine A, Marrero I, Olson N, Siegel C, Mc– Cormick N. The correlation between blood levels of ibu– profen and clinical analgesic response. Clin Pharmacol Ther 1986;40:1–7.

21. Seymour RA, Ward-Booth P, Kelly PJ. Evaluation of dif– ferent doses of soluble ibuprofen and ibuprofen tablets in postoperative dental pain. Br J Oral Maxillofac Surg 1996; 34:110–4.

22. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse ef– fects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 2010;24:121–32.

23. Viteri OA, England JA, Alrais MA, Lash KA, Villegas MI, Ashimi Balogun OA, et al. Association of nonsteroidal antiinflammatory drugs and postpartum hypertension in women with preeclampsia with severe features. Obstet Gy– necol 2017;130:830–5.

24. Sutton CD, Carvalho B. Optimal pain management after cesarean delivery. Anesthesiol Clin 2017;35:107–24.

25. Valentine AR, Carvalho B, Lazo TA, Riley ET. Scheduled acetaminophen with as-needed opioids compared to as– needed acetaminophen plus opioids for post-cesarean pain management. Int J Obstet Anesth 2015;24:210–6.

26. Cardoso MM, Leite AO, Santos EA, Gozzani JL, Mathias LA. Effect of dexamethasone on prevention of postopera– tive nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial. Eur J Anaesthesiol 2013;30:102–5.

27. Davis KM, Esposito MA, Meyer BA. Oral analgesia com– pared with intravenous patient-controlled analgesia for pain after cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol 2006;194:967–71.

28. McNicol ED, Ferguson MC, Hudcova J. Patient controlled opioid analgesia versus non-patient controlled opioid anal– gesia for postoperative pain. Cochrane Database of System– atic Reviews 2015, Issue 6. Art. No.: CD003348.

29. Lavand’homme PM, Roelants F, Waterloos H, De Kock MF. Postoperative analgesic effects of continuous wound infiltration with diclofenac after elective cesarean delivery. Anesthesiology 2007;106:1220–5. 


30. Eslamian L, Jalili Z, Jamal A, Marsoosi V, Movafegh A. Transversus abdominis plane block reduces postoperative pain intensity and analgesic consumption in elective cesar– ean delivery under general anesthesia. J Anesth 2012;26: 334–8. 


31. Mukhtar K. Transversus abdominis plane (TAP) block. New York (NY): The New York School of Regional Anes– thesia; 2009. Available at: http://www.nysora.com/files/ 2013/pdf/(v12p28-33)TAPBlock.pdf. Retrieved March 9, 2018. 


32. Bateman BT, Cole NM, Maeda A, Burns SM, Houle TT, Huybrechts KF, et al. Patterns of opioid prescription and use after cesarean delivery. Obstet Gynecol 2017;130:29–35. 


33. Osmundson SS, Schornack LA, Grasch JL, Zuckerwise LC, Young JL, Richardson MG. Postdischarge opioid use after cesarean delivery. Obstet Gynecol 2017;130:36–41. 


34. Prabhu M, McQuaid-Hanson E, Hopp S, Burns SM, Leffert LR, Landau R, et al. A shared decision-making intervention to guide opioid prescribing after cesarean delivery. Obstet Gynecol 2017;130:42–6. 


35. Ilett KF, Kristensen JH. Drug use and breastfeeding. Expert Opin Drug Saf 2005;4:745–68. 


36. Rigourd V, de Villepin B, Amirouche A, Bruneau A, Ser– aissol P, Florent A, et al. Ibuprofen concentrations in human mature milk–first data about pharmacokinetics study in breast milk with AOR-10127 “Antalait” study. Ther Drug Monit 2014;36:590–6. 


37. Spigset O, Hagg S. Analgesics and breast-feeding: safety considerations. Paediatr Drugs 2000;2:223–38. 


38. Sachs HC. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Commit– tee on Drugs. Pediatrics 2013;132:e796–809. 


39. Montgomery A, Hale TW. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2012. Academy of Breastfeeding Medicine. Breast– feed Med 2012;7:547–53. 


40. National Library of Medicine. Ibuprofen. In: Drugs and Lactation Database (LactMed). Available at: https://toxnet. nlm.nih.gov/cgi-bin/sis/search2/f?./temp/;uu12jC:1. Retrieved March 23, 2018. 


41. Wischnik A, Manth SM, Lloyd J, Bullingham R, Thompson JS. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol 1989;36:521–4. 


42. National Library of Medicine. Ketorolac. In: Drugs and Lactation Database (LactMed). Bethesda (MD): NLM; 2018. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/ search2/r?dbs+lactmed:@term+@DOCNO+153. Retrieved April 2, 2018. 


43. Hendrickson RG, McKeown NJ. Is maternal opioid use hazardous to breast-fed infants?. Clin Toxicol (Phila) 2012;50:1–14.

44. Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lotsch J, Roots I, et al. Pharmacokinetics of codeine and its metab– olite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 2007;7:257–65.

45. Coller JK, Christrup LL, Somogyi AA. Role of active me– tabolites in the use of opioids. Eur J Clin Pharmacol 2009; 65:121–39.

46. Cascorbi I. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur J Clin Invest 2003;33(suppl):17–22.

47. Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, et al. Clinical Pharmacogenetics Imple– mentation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clinical Pharmacogenetics Implementation Con– sortium. Clin Pharmacol Ther 2012;91:321–6.

48. Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Phar– macogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006;368:704.

49. U.S. Food and Drug Administration. FDA drug safety com– munication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. Silver Spring (MD): FDA; 2017. Available at: https://www. fda.gov/Drugs/DrugSafety/ucm549679.htm. Retrieved March 9, 2018.

50. Ingelman-Sundberg M. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J Intern Med 2001;250:186–200.

51. Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, et al. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. Br J Pharmacol 2010;160:919–30.

52. Linares OA, Fudin J, Daly AL, Boston RC. Individualized hydrocodone therapy based on phenotype, pharmacoge– netics, and pharmacokinetic dosing. Clin J Pain 2015;31: 1026–35.

53. Boswell MV, Stauble ME, Loyd GE, Langman L, Ramey– Hartung B, Baumgartner RN, et al. The role of hydromor– phone and OPRM1 in postoperative pain relief with hydro– codone. Pain Physician 2013;16:E227–35.

54. National Library of Medicine. Morphine. In: Drugs and Lactation Database (LactMed). Available at: http://toxnet. nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term +@DOCNO+370. Retrieved March 9, 2018.

55. Kelly LE, Chaudhry SA, Rieder MJ, ’t Jong G, Moretti ME, Lausman A, et al. A clinical tool for reducing central ner– vous system depression among neonates exposed to codeine through breast milk. PLoS One 2013;8:e70073.

56. Opioid use and opioid use disorder in pregnancy. Commit– tee Opinion No. 711. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e81–94.

57. Gopman S. Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin North Am 2014;41:213–28. 


58. Jones HE, Deppen K, Hudak ML, Leffert L, McClelland C, Sahin L, et al. Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers. Am J Obstet Gynecol 2014;210:302–10. 


59. Screening for perinatal depression. Committee Opinion No. 630. American College of Obstetricians and Gynecol– ogists. Obstet Gynecol 2015;125:1268–71. 


60. Virginia Department of Health. Pregnancy-associated deaths from drug overdose in Virginia, 1999-2007: a report from the Virginia Maternal Mortality Review Team. Richmond (VA): VDH; 2015. Available at: http://www.vdh. virginia.gov/content/uploads/sites/18/2016/04/Final– Pregnancy-Associated-Deaths-Due-to-Drug-Overdose.pdf. Retrieved March 9, 2018. 


61. Maryland Department of Health and Mental Hygiene. Maryland maternal mortality review 2016 annual report. Baltimore (MD): DHMH; 2016. Available at: http: //health ymaryland.org/wp-content/uploads/2011/05/ MMR_Report_2016_clean-copy_FINAL.pdf. Retrieved March 9, 2018. 


62. American Society of Addiction Medicine. Public policy statement on the use of naloxone for the prevention of opioid overdose deaths. Chevy Chase (MD): ASAM; 2016. Available at: https://www.asam.org/docs/default– source/public-policy-statements/use-of-naloxone-for-the– prevention-of-opioid-overdose-deaths-final.pdf. Retrieved March 9, 2018.

63. Dowell D, Haegerich TM, Chou R. CDC guideline for pre– scribing opioids for chronic pain – United States, 2016 [published erratum appears in MMWR Recomm Rep 2016; 65:295]. MMWR Recomm Rep 2016; 65(RR-1):1–49. Available at: https: //www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm. Retrieved March 9, 2018. 


64.National Academies of Sciences, Engineering, and Medi– cine. Pain management and the opioid epidemic. Balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): National Academies Press; 2017.